polyclonal rabbit anti phospo syk ab (Santa Cruz Biotechnology)
Structured Review

Polyclonal Rabbit Anti Phospo Syk Ab, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 65 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+fas+ab/FAS+siRNA/pmc07746524-268-5-10
Average 93 stars, based on 65 article reviews
Images
1) Product Images from "Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model"
Article Title: Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model
Journal: Mucosal Immunology
doi: 10.1038/s41385-019-0167-z
Figure Legend Snippet: Human CD89 is functional in Tg mice. a Flow-cytometric analysis of CD89 expression and mIgA binding on CD89 tg/wt /LyzM cre/wt (black) and littermate (filled grey) bone marrow-derived macrophages (BMDM). Fluorescence-minus-one (FMO) control is shown in open grey line. Right: Binding of fluorescently labelled polyclonal mIgA is restricted to the mCherry low population. b Flow-cytometry binding studies of various human IgA species. BMDM from CD89 tg/wt /LyzM cre/wt (black) and littermates (grey) were incubated with polyclonal human mIgA and IgAM preparations and monoclonal human IgA1 and IgA2. Bound IgA was detected with αIgA-PE. Geometric MFI ± SD from mCherry low-expressing cells from duplicates are shown. c CD89 is associated constitutively with dimeric FcRγ-chain. CD89 was immunoprecipitated (IP) with an anti-CD89 antibody (clone A59) from whole-cell extracts (right panel) prepared from unstimulated BMDM from a CD89 tg/wt /LyzM cre/wt mouse. Protein was eluted and run on SDS-PAGE under non-reducing conditions. The membrane was probed with an anti-FcRγ chain antibody. d CD89 mediates induction of Syk and p42/44 phosphorylation. CD89 tg/wt /LyzM cre/wt and littermate (LM) BMDM cells were incubated with IgA-coated beads for the indicated times. Samples were run on SDS-PAGE and Syk and p42/44 phosphorylation were determined using phospho-specific antibodies. The same membrane was reprobed with anti-Syk and anti-p42/44 antibodies. e CD89 facilitates uptake of IgA-coated beads. CD89 tg/wt /LyzM cre/wt (black) and littermate (grey) BMDMs cultured in eight-well slides were incubated at 37 °C with IgA- or IgG-coated beads at a cell-to-bead ratio of 25:1 for 30 min. Slides were stained with HOECHST and anti-kappa-PE to visualise nuclei and external beads and imaged. The number of internalised beads per cell were counted manually. Over 100 BMDM cells per stimulus were counted. The percentage of cells with internalised numbers of beads are shown
Techniques Used: Functional Assay, Expressing, Binding Assay, Derivative Assay, Fluorescence, Control, Flow Cytometry, Incubation, Immunoprecipitation, SDS Page, Membrane, Phospho-proteomics, Cell Culture, Staining
Figure Legend Snippet: Human CD89 mediates cytokine production by BMDM. a BMDM from CD89 tg/wt /LyzM cre/wt (black) and littermates (grey) were cultured for 24 h on surface-bound polyclonal mIgA, IgAM or IgG. Cytokine concentrations in pg/ml (mean ± SEM, n = 3 individual mice) are shown. The effect of the CD89 protein was tested using a two-way ANOVA with Sidak’s multiple comparison test. b CD89 tg/wt /LyzM cre/wt BMDM were incubated overnight with mIgA-coated (●) or BSA-coated beads (▲) at varying ratios. Cytokine concentrations in pg/ml (means ± SD) from duplicates are shown
Techniques Used: Cell Culture, Comparison, Incubation
Figure Legend Snippet: Reactivity of human polyclonal Igs to Cal7 and PR8 H1N1 strain
Techniques Used:
Figure Legend Snippet: Polyclonal human Ig preparations inhibit Cal7 ( a , c ) and PR8 ( b , d ) H1N1 influenza neuraminidase activity and virus plaque formation in vitro. a , b Neuraminidase activity assay. IC 50 concentrations are shown in brackets. c , d MDCK virus plaque neutralisation assay. Error bars indicate SD
Techniques Used: Activity Assay, Virus, In Vitro
Figure Legend Snippet: Human polyclonal mIgA protects mice from PR8 H1N1-induced death in a CD89-dependent manner. In total, 2.5 mg of Ig preparation was administered i.n. as indicated in ( a ) and mice were infected i.n. with 500 PFU of PR8 H1N1 on day 0. b Percentage of body weight of CD89 tg/wt /LyzM cre/wt (black) and littermates (grey) treated with IgG (square), mIgA (circle) or PBS (diamond). c Minimum weight as a percentage of day 0. Mean ± SEM from two pooled experiments ( n = 5–15 mice). The shaded area indicates mice euthanised at the humane endpoint. Unpaired t test was performed to compare CD89 tg/wt /LyzM cre/wt and littermates
Techniques Used: Infection
Figure Legend Snippet: Human polyclonal Igs protect from weight loss and IgG reduces Cal7 and PR8 H1N1 viral titres in vivo. In total, 2.5 mg of Ig preparation was administered i.n. to CD89 tg/wt /LyzM cre/wt mice and mice infected i.n. with H1N1 influenza on day 0 as indicated in Fig. 7a. Lung viral titres at day 5 ( a , b ) and weight ( c , d ) after i.n. inoculation of 10 4 PFU Cal7 ( a , c ) and 500 PFU PR8 H1N1 ( b , d ) on day 0 are shown. Mean ± SEM values from one experiment are shown ( n = 5) for each virus. One-way ANOVA with Dunn’s multiple comparison to the PBS group is shown. ** P < 0.01, *** P < 0.001, **** P < 0.0001
Techniques Used: In Vivo, Infection, Virus, Comparison
Figure Legend Snippet: Human polyclonal Igs reduce influenza-induced transcriptional profile and protein levels in the lung. mRNA transcriptional levels ( a , b ) and protein cytokine levels ( c , d ) of homogenised lungs at day 5 after i.n. inoculation of 10 4 PFU Cal7 ( a , c ) and 500 PFU PR8 ( b , d ) H1N1 and Ig treatment as indicated in Fig. are shown. CNRQ, calibrated normalised relative quantities from n = 3–5 animals are shown for each experiment. Mean protein concentrations from one experiment are shown ( n = 4–5) for each virus. One-way ANOVA with Dunnet’s multiple comparison to the PBS group is shown. ** P < 0.01, *** P < 0.001, **** P < 0.0001, n.d. not done
Techniques Used: Virus, Comparison
Related Articles
Staining:Article Title: Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome. Article Snippet: .. The slides were stained using an AEC kit (HistoStain SP kit, Zymed, San Francisco, CA, USA) with the following first antibodies: (i) a murine monoclonal anti-Fas antibody (ZB-4 clone, Upstate Biotechnology Inc, Lake Placid, NY, USA); (ii) a |
